Radiotherapy for Stage IIA seminoma: The Northern Israel Oncology Center Experience, 1971-2010.

Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst (2005) 3.73

Mortality after cure of testicular seminoma. J Clin Oncol (2004) 2.53

Role of positron emission tomography in urological oncology. BJU Int (2010) 2.32

Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer. Acta Oncol (2007) 1.18

Radiotherapy for stages IIA/B testicular seminoma: final report of a prospective multicenter clinical trial. J Clin Oncol (2003) 1.08

Management of localized seminoma, stage I-II: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009. Urology (2011) 0.96

Seminoma of the testis: long-term beneficial and deleterious results of radiation. Int J Radiat Oncol Biol Phys (1992) 0.94

Evolving concepts in stage I seminoma. BJU Int (2009) 0.87

Review of late complications of treatment and late relapse in testicular cancer. J Natl Compr Canc Netw (2006) 0.85

Radiotherapy treatment planning for testicular seminoma. Int J Radiat Oncol Biol Phys (2012) 0.85

Adjuvant radiation therapy for early stage seminoma: proton versus photon planning comparison and modeling of second cancer risk. Radiother Oncol (2012) 0.84

Radiotherapy for stages I and II testicular seminoma: results and morbidity in 238 patients. Br J Radiol (1995) 0.84

PET in testicular cancer. Methods Mol Biol (2011) 0.83

Radiotherapy for stages I and IIA/B testicular seminoma. Int J Cancer (1999) 0.83

Management of Stage II testicular seminoma over a period of 40 years. Urol Oncol (2008) 0.83

Long-term outcomes of radiotherapy for stage II testicular seminoma--the Mayo Clinic experience. Urol Oncol (2012) 0.81

Radiotherapy for stage II testicular seminoma. Int J Radiat Oncol Biol Phys (2001) 0.79

Bone marrow-sparing intensity-modulated radiation therapy for Stage I seminoma. Acta Oncol (2011) 0.79

Improving the therapeutic ratio by using proton therapy in patients with stage I or II seminoma. Am J Clin Oncol (2013) 0.78

A risk-adapted strategy of radiotherapy or cisplatin-based chemotherapy in stage II seminoma. Urol Oncol (2011) 0.78